Shuji Asai, Mochihito Suzuki, Ryota Hara, Yuji Hirano, Satomi Nagamine, Tetsuya Kaneko, Takahito Suto, Tadashi Okano, Yutaka Yoshioka, Makoto Hirao, Hiroki Wakabayashi, Takayoshi Fujibayashi, Tatsuo Watanabe, Yuya Takakubo, Hajime Ishikawa, Yoshihisa Nasu, Toki Takemoto, Takefumi Kato, Eiji Torikai, Kensuke Koyama, Hideki Takagi, Toshifumi Fujiwara, Yasumori Sobue, Yoshifumi Ohashi, Tsuyoshi Nishiume, Kenya Terabe, Masayo Kojima, Toshihisa Kojima, Shiro Imagama
OBJECTIVE: To compare the effectiveness of methotrexate (MTX) as initial therapy in patients with late-onset and younger-onset rheumatoid arthritis (LORA and YORA). METHODS: Of 114 patients with YORA and 96 patients with LORA, defined as RA occurring at ≥65 years of age, enrolled in a multicentre RA inception cohort study, 71 and 66 patients who had been followed up to 6 months after starting MTX treatment were included in this study. RESULTS: Proportions of patients on MTX treatment at 6 months were 96% and 92% in the YORA and LORA groups, respectively...
March 6, 2024: Modern Rheumatology